When it comes to what’s happening in the life sciences, STAT readers are the experts. So earlier this month, I asked readers of the First Opinion newsletter to answer two questions: What story do you think went underdiscussed in 2024? What should we all be paying attention to in 2025?
Many responded, sharing thoughts about policies, the high cost of health care, and much more. Below, you can find a selection of answers.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
